Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Using Mobile Phone Text Messaging System to Improve Exclusive Breastfeeding Rate in a Resource-poor Caribbean Island

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03853850
Recruitment Status : Completed
First Posted : February 26, 2019
Last Update Posted : March 3, 2020
Sponsor:
Collaborators:
Public Hospital Roatan, Honduras
University of California, San Francisco
Information provided by (Responsible Party):
University of California, Davis

Brief Summary:
This study will evaluate whether sending educational and supportive mobile phone text messages to mothers of infants, from babies' day of birth until 6 months of age, increases the rate of exclusive breastfeeding in Roatan, Honduras.

Condition or disease Intervention/treatment Phase
Breastfeeding Breastfeeding, Exclusive Behavioral: Mobile phone text messages Not Applicable

Detailed Description:

Encouraging and educational text messages and animations were created based on barriers to breastfeeding found during preceding focus groups and a baseline survey. Messages were written in English and translated into Spanish, with back-translation to ensure accuracy. Mothers who plan to or are already breastfeeding will be recruited and invited to participate in the study in the post-partum ward after delivery at Public Hospital Roatán. Written informed consent will be obtained. Three animated videos will be shown to mothers at enrollment providing information regarding breastfeeding technique, breastfeeding encouragement and general breastfeeding information. SMS messages will start at time of enrollment and continue through six months after enrollment. Messages will be delivered through Telerivet, an SMS interactive platform designed to send the educational and motivational messages to mothers' cell phones.

The intervention group will be polled when infants turn two months, four months, and six months regarding their infant feeding practices through Telerivet via SMS messaging. The primary outcome of this study is exclusive breastfeeding at 2 months of age, as compared to the exclusive breastfeeding rate obtained in our baseline cross sectional survey. Exclusive breastfeeding will be defined as giving only mother's breastmilk in the 24 hours preceding the interview. Mothers will also be asked if they are breastfeeding at all, age of infant when they last gave breast milk, the incidence of diarrheal illness in the past two weeks, and any other foods / liquids given to infant.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 582 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Strengthening Babies Through Mobile Health
Actual Study Start Date : September 28, 2017
Actual Primary Completion Date : July 3, 2019
Actual Study Completion Date : November 10, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Breastfeeding

Arm Intervention/treatment
Experimental: Intervention
Participating mothers will receive mobile phone text messages during their babies' first 6 months of life. Messages will educate mothers on breastfeeding and proper infant feeding.
Behavioral: Mobile phone text messages
From their babies' day of birth until 6 months of age, participating mothers will receive supportive and educational text messages to promote breastfeeding. Messages will be on benefits of breastfeeding, newborn hunger cues, proper latch technique, healthy infant feeding practice, and maternal self care. Messages will be sent regularly, initially several messages every day during the babies' first few weeks of life, then few messages every week. A total of 158 (***) messages will be sent. Messages will be sent in English or in Spanish depending on participant language preference.




Primary Outcome Measures :
  1. Exclusive breastfeeding rate at 2 months of age [ Time Frame: 2 months after date of enrollment ]
    Proportion of infants exclusive breastfeeding at 2 months of age. Exclusive breastfeeding defined as only breastmilk in the 24 hours preceding data collection


Secondary Outcome Measures :
  1. Exclusive breastfeeding rate at 4 months of age [ Time Frame: 4 months after date of enrollment ]
    Proportion of infants exclusively breastfeeding at 4 months of age. Exclusive breastfeeding defined as only breastmilk in the 24 hours preceding data collection

  2. Exclusive breastfeeding rate at 6 months of age [ Time Frame: 6 months after date of enrollment ]
    Proportion of infants exclusively breastfeeding at 6 months of age. Exclusive breastfeeding defined as only breastmilk in the 24 hours preceding data collection

  3. Breastfeeding rate at 4 months of age [ Time Frame: 4 months after date of enrollment ]
    Proportion of infants with any amount of breastfeeding at 4 months of age

  4. Breastfeeding rate at 6 months of age [ Time Frame: 6 months after date of enrollment ]
    Proportion of infants with any amount of breastfeeding at 6 months of age

  5. Diarrheal disease at 2 months of age [ Time Frame: 2 months after date of enrollment ]
    Diarrheal disease incidence at 2 months of age. Diarrheal disease defined as watery stool during 2 weeks preceding data collection

  6. Diarrheal disease at 4 months of age [ Time Frame: 4 months after date of enrollment ]
    Diarrheal disease incidence at 4 months of age. Diarrheal disease defined as watery stool during 2 weeks preceding data collection

  7. Diarrheal disease at 6 months of age [ Time Frame: 6 months after date of enrollment ]
    Diarrheal disease incidence at 6 months of age. Diarrheal disease defined as watery stool during 2 weeks preceding data collection

  8. Infant feeding practice at 2 months of age [ Time Frame: 2 months after date of enrollment ]
    Other types of food given during 24 hours preceding data collection at 2 months of age

  9. Infant feeding practice at 4 months of age [ Time Frame: 4 months after date of enrollment ]
    Other types of food given during 24 hours preceding data collection at 4 months of age

  10. Infant feeding practice at 6 months of age [ Time Frame: 6 months after date of enrollment ]
    Other types of food given during 24 hours preceding data collection at 6 months of age



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   Female
Gender Based Eligibility:   Yes
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Recently delivered full term infants (>37 weeks gestation, less than 72 hours old)
  • 18 years of age or older, or emancipated minor, or if parent able to consent if <18 years of age
  • Intent to breastfeed
  • Own a phone that can receive SMS messages
  • Able to send SMS reply messages

Exclusion Criteria:

  • Mothers who report they can not read in Spanish nor English

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03853850


Locations
Layout table for location information
Honduras
Public Hospital Roatan
Coxen Hole, Roatan, Honduras
Sponsors and Collaborators
University of California, Davis
Public Hospital Roatan, Honduras
University of California, San Francisco
Investigators
Layout table for investigator information
Principal Investigator: Caroline Chantry, MD University of California, Davis
Principal Investigator: Lisa Rasmussen, MD University of California, Davis
  Study Documents (Full-Text)

Documents provided by University of California, Davis:
Layout table for additonal information
Responsible Party: University of California, Davis
ClinicalTrials.gov Identifier: NCT03853850    
Other Study ID Numbers: 16-19171
First Posted: February 26, 2019    Key Record Dates
Last Update Posted: March 3, 2020
Last Verified: March 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No